Device Trial Radar · NCT03912584
Study Comparing the P200TE and the P200TxE in Glaucoma Patients
Last checked: Nov 20, 2026Latest source record: Sep 23, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
10
Actual
Start
Apr 29, 2019
Primary completion
Apr 30, 2019
Study completion Apr 30, 2019
Sponsor
- Lead sponsor
- Optos, PLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 11, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study evaluates the image quality between two OCT devices.
Conditions
- Glaucoma
Interventions
P200TEDevice
The P200TE Ophthalmoscope provides widefield Scanning Laser Ophthalmoscope (SLO) fundus imaging and Optical Coherence Tomography (OCT) imaging in one device.
P200TxEDevice
The P200TxE Ophthalmoscope provides widefield Scanning Laser Ophthalmoscope (SLO) fundus imaging and Optical Coherence Tomography (OCT) imaging in one device.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Qualitative B-Scan AssessmentTime frame: 1 day (start: April 29, 2019 - completed: April 30, 2019)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Medical Center Ophthalmology Associates
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.